Items tagged with Drug-resistant TB
MSF TB clinical trial finds shorter, more effective, and safer treatment (post)
New results show a much shorter treatment regimen for drug-resistant TB is superior to current options.
Highlights from the 52nd Union World Conference on Lung Health: Official press statements (post)
For the second year in a row, the 52nd Union World Conference on Lung Health was held virtually due to the COVID-19 pandemic on 19-22 October 2021 under the theme Lung Health for All: Solutions for a New Era. The Union World Conference is world’s largest gathering of clinicians and public health workers, health program managers, policymakers, researchers and advocates working to end the suffering caused by lung disease, with a focus specifically on the challenges faced by low- and lower-middle income populations.
RESIST-TB October 2021 newsletter (post)
RESIST-TB released its October 2021 newsletter with the latest research publications on drug-resistant TB.
A survivor’s take: Why India must ensure a shorter oral regimen to treat drug-resistant TB (post)
Despite the emergence of new medicines to treat the disease, the country’s existing health system offers little help in reducing the suffering of patients.
Global individual patient data platform for drug-resistant TB treatment (post)
In order to increase the knowledge base for normative guidance on optimal treatment modalities for drug-resistant tuberculosis (DR-TB), WHO is announcing a publicly accessible global individual patient data (IPD) platform for drug-resistant tuberculosis treatment (DR-TB-IPD). This will be a secure but accessible platform containing outcomes of over 10,000 drug-resistant TB patients as the starting point and expanding this with data received in response to a recent public call for data.
Improved TB tests and treatments are vital to overcoming drug resistance (post)
In the face of the COVID-19 pandemic, tuberculosis mortality has started to increase for the first time in a decade. In 2020 alone, more than 1.5 million people died from TB. Every year, about half a million people develop a drug-resistant form of TB (DR-TB).
RESIST-TB November 2021 newsletter (post)
RESIST-TB released its November 2021 newsletter with the latest research publications on drug-resistant TB.
Free online course: Programmatic and clinical management of drug-resistant TB (post)
The International Union Against Tuberculosis and Lung Disease launched a new free online course that provides all the information needed for the programmatic and clinical management of drug-resistant TB (DR-TB) from the epidemiology and diagnosis of DR-TB to the clinical presentation, treatment, infection control and reporting. The course is specifically designed for clinical officers, nurses, paramedics and other health workers.
Researchers first to predict when bacteria may become resistant to antibiotics (post)
Scientists have spotted signs of ‘pre-resistance’ in bacteria for the first time – signs that particular bacteria are likely to become resistant to antibiotics in the future – in a new study led by UCL and Great Ormond Street Hospital researchers.
TaBriX, University of Manchester and TB Alliance to develop drug-resistant TB treatments (post)
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.
Page 72 of 117 · Total posts: 0
←First 71 72 73 Last→